# Minor Use Minor Species Development of Drugs (R01)

Source: https://welltoldgrants.com/grants/par-24-216-minor-use-minor-species-development-of-drugs-r01/  
Official notice: https://www.grants.gov/search-results-detail/354573

> Food and Drug Administration is offering grants of up to $250,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make $250,000 in total. Applications close on January 29, 2027.

| Field | Value |
|---|---|
| Opportunity number | PAR-24-216 |
| Agency | Food and Drug Administration |
| Status | Open |
| Deadline | January 29, 2027 |
| Award ceiling | $250,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | $250,000 |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

• Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

## What the grant funds

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516. FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

## Questions people ask

### Who can apply for Minor Use Minor Species Development of Drugs (R01)?

Food and Drug Administration accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Minor Use Minor Species Development of Drugs (R01)?

Closes January 29, 2027 (90 days left). Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

Awards of up to $250,000 each. About $250,000 in total.